Interna Therapeutics Partners with Daiichi Sankyo to Enhance MNM Technology for Targeted Drug Delivery Interna Therapeutics has formed a research collaboration with Daiichi Sankyo to enhance drug delivery systems utilizing MNM technology. This partnership aims to improve the efficacy of targeted therapies.

Interna Therapeutics Partners with Daiichi Sankyo to Enhance MNM Technology for Targeted Drug Delivery #Israel #Daiichi_Sankyo #Petach_Tikva #Interna_Therapeutics #MNM_Technology

Eltek Secures $5.3 Million Order, Updates Q1 2026 Forecast Eltek Ltd. announces a significant $5.3 million order from an international customer while providing updates about its first quarter 2026 outlook.

Eltek Secures $5.3 Million Order, Updates Q1 2026 Forecast #Israel #Petach_Tikva #Printed_Circuit_Boards #Eltek_Ltd. #NASDAQ:_ELTK

Eltek Ltd. Reports Financial Performance for the Year and Q4 2025 Amid Operational Challenges Eltek Ltd. has released its financial results for the full year and fourth quarter of 2025, highlighting revenue growth despite challenges.

Eltek Ltd. Reports Financial Performance for the Year and Q4 2025 Amid Operational Challenges #Israel #Petach_Tikva #PCBs #Eltek_Ltd #NASDAQ_ELTK

Eltek Secures $12.2 Million in Defense Purchase Orders from U.S. Client Eltek Ltd. announces a significant $12.2 million order from a U.S. defense customer, further solidifying its market position in high-demand sectors.

Eltek Secures $12.2 Million in Defense Purchase Orders from U.S. Client #Israel #Petach_Tikva #Printed_Circuit_Boards #Defense_Industry #Eltek_Ltd

Eltek Secures $2.4 Million Defense Purchase Orders Amid Technological Advancements Eltek Ltd. has announced a significant milestone by receiving purchase orders worth $2.4 million from a leading Israeli defense company, focusing on advanced printed circuit board technologies.

Eltek Secures $2.4 Million Defense Purchase Orders Amid Technological Advancements #Israel #Petach_Tikva #Eltek #PCB_Technology #Defense_Orders

Eltek Ltd. Posts Impressive Financial Results for Q2 2025, Showcasing Strong Growth and Profitability Eltek Ltd. has reported remarkable second-quarter results for 2025, with significant revenue growth and improved margins, driven by strong demand in its defense and medical segments.

Eltek Ltd. Posts Impressive Financial Results for Q2 2025, Showcasing Strong Growth and Profitability #Israel #Petach_Tikva #Q2_2025 #PCB_Solutions #Eltek_Ltd.

Medison Strengthens Its Executive Team with New CBO and CCO Appointments Medison enhances its leadership with the appointment of Shay Tamari as Chief Business Officer and Tali Mirsky as Chief Legal & Compliance Officer, aiming to amplify its global reach.

Medison Strengthens Its Executive Team with New CBO and CCO Appointments #Israel #Petach_Tikva #Medison #Shay_Tamari #Tali_Mirsky

Medison Strengthens Global Leadership Team with Strategic Appointments in Business and Compliance Medison announces key appointments of Shay Tamari and Tali Mirsky to strengthen its global leadership team, enhancing capabilities for biotech commercialization.

Medison Strengthens Global Leadership Team with Strategic Appointments in Business and Compliance #Israel #Petach_Tikva #Medison #Shay_Tamari #Tali_Mirsky

Strategic Partnership Aims to Enhance Cancer Treatment with Gadolinium-160 Supply ASP Isotopes and Isotopia have formed a strategic alliance to enhance the production of Terbium-161, aiming to improve advanced cancer therapies and address supply challenges.

Strategic Partnership Aims to Enhance Cancer Treatment with Gadolinium-160 Supply #USA #ASP_Isotopes #Isotopia #Petach_Tikva #Terbium-161

Eltek Ltd. Reports First Quarter Financials for 2025: Key Highlights and Future Outlook Eltek Ltd. has unveiled its financial results for Q1 2025, showcasing revenue growth amidst challenges in gross margins. Join us as we explore their performance and future strategies.

Eltek Ltd. Reports First Quarter Financials for 2025: Key Highlights and Future Outlook #Israel #financial_results #Petach_Tikva #Q1_2025 #Eltek_Ltd.

Eltek Ltd. Announces 2024 Financial Results Amid Strategic Transition Plans Eltek Ltd. reports financial results for 2024, revealing a slight revenue decline accompanied by a strategic transition plan aimed at future growth.

Eltek Ltd. Announces 2024 Financial Results Amid Strategic Transition Plans #Israel #financial_results #Petach_Tikva #Eltek_Ltd #PCB_Manufacturing

Isotopia and LIVEKIDNEY.BIO Forge Innovative Partnership to Revolutionize Lupus Treatment Isotopia announces a game-changing partnership with LIVEKIDNEY.BIO, aimed at developing a vital component for lupus nephritis therapy with potential to enhance patient lives.

Isotopia and LIVEKIDNEY.BIO Forge Innovative Partnership to Revolutionize Lupus Treatment #Israel #LIVEKIDNEY.BIO #Isotopia #Petach_Tikva #LupusNephritis

Isotopia and LIVEKIDNEY.BIO Team Up to Revolutionize Lupus Nephritis Treatment A transformative partnership between Isotopia and LIVEKIDNEY.BIO aims to enhance lupus nephritis therapies, promising better patient outcomes.

Isotopia and LIVEKIDNEY.BIO Team Up to Revolutionize Lupus Nephritis Treatment #Israel #Lupus_Nephritis #LIVEKIDNEY.BIO #Isotopia #Petach_Tikva

Isotopia and LIVEKIDNEY.BIO Collaborate to Enhance Lupus Treatment Isotopia proudly announces an innovative partnership with LIVEKIDNEY.BIO, focusing on advancing lupus nephritis treatment through cutting-edge therapy development.

Isotopia and LIVEKIDNEY.BIO Collaborate to Enhance Lupus Treatment #Israel #LIVEKIDNEY.BIO #Isotopia #Petach_Tikva #Lupus

Revolutionary Lupus Treatment Emerging from Isotopia and LIVEKIDNEY.BIO Partnership Isotopia's partnership with LIVEKIDNEY.BIO heralds a new era in lupus nephritis treatment, promising enhanced care and outcomes for millions globally.

Revolutionary Lupus Treatment Emerging from Isotopia and LIVEKIDNEY.BIO Partnership #Israel #Lupus_Nephritis #LIVEKIDNEY.BIO #Isotopia #Petach_Tikva